Examining the effects of NOAC therapy on stroke severity and outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between non-vitamin K antagonist oral anticoagulant (NOAC) therapy and the severity of acute strokes in patients with atrial fibrillation. It aims to analyze how adherence to NOAC treatment and drug levels at the time of stroke impact short-term and long-term outcomes. By measuring NOAC levels through blood sampling during acute stroke events, the study seeks to provide insights into optimal management strategies for stroke prevention in patients already on NOAC therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Atrial fibrillation
* Under dabigatran, rivaroxaban, apixaban or edoxaban therapy.
* Developing ischemic stroke, transient ischemic attack or intracranial hemorrhage during NOAC therapy.

Exclusion Criteria:

* Refuse to provide blood sample for non-vitamin K antagonist oral anticoagulant (NOAC) concentration measurement.
* Refuse to provide informed consent.

Where it's running

• National Taiwan University Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Study coordinator: Shin Yi Lin, MS
• Email: 102067@ntuh.gov.tw
• Phone: 0972651956

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Infliximab treatment for Crohn's disease with drug monitoring

  This study is testing if adjusting infliximab treatment based on drug levels helps people with active perianal fistulizing Crohn's disease feel better compared to standard fixed dosing.

  Recruiting Phase 4 Asan Medical Center · Seoul · NCT06051253

• Ofloxacin blood levels and side effects in older adults with bone and joint infections.

  This project will test whether higher blood levels of ofloxacin on day 3 cause more side effects in people over 65 being treated for bone and joint infections.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT04496024

• Personalized linezolid dosing with therapeutic drug monitoring during the BPaL regimen for MDR-TB

  This project will see if adjusting linezolid doses using therapeutic drug monitoring helps people aged 15 and older in Guinea with multidrug-resistant tuberculosis tolerate the 6-month BPaL regimen with fewer serious side effects.

  Recruiting Phase 4 ASST Fatebenefratelli Sacco · Conakry · NCT07477119

• New device to improve intravenous therapy safety

  This study is testing a new device that aims to make intravenous treatments safer and more effective for patients by reducing risks like infections and catheter problems.

  Recruiting Fundacion Miguel Servet · Pamplona, Navarre · NCT06938750

• Home microsampling to monitor cancer drug levels

  This tests whether tiny blood samples taken at home can reliably measure levels of certain oral and injectable cancer drugs in adults using those medicines.

  Recruiting Leiden University Medical Center · Leiden, South Holland · NCT06545292

• Evaluating antibiotic effectiveness in patients with infections

  This study is testing how well beta-lactam antibiotics work for patients with infections by checking if they get the right amount of the medicine in their system to help them recover.

  Recruiting Imperial College London · London · NCT06427317

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.